Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in Br J Dermatol

Retrieve available abstracts of 145 articles:
HTML format
Text format



Single Articles


    April 2017
  1. GUALANO MR, Osella-Abate S, Scaioli G, Marra E, et al
    Prognostic role of Histologic regression in primary cutaneous melanoma: A Systematic Review and Meta-analysis.
    Br J Dermatol. 2017 Apr 7. doi: 10.1111/bjd.15552.
    PubMed     Text format     Abstract available


  2. NIJSTEN T, Wakkee M
    The four Ws of skin cancer surveillance in patients with melanoma: Why? Who? When? Where?
    Br J Dermatol. 2017;176:839-841.
    PubMed     Text format    


    March 2017
  3. LOTT JP, Wang Q, Titus LJ, Onega T, et al
    Temporal Trends in Healthcare Utilization following Primary Melanoma Diagnosis among Medicare Beneficiaries.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15530.
    PubMed     Text format     Abstract available


  4. KARIMKHANI C, Green AC, Nijsten T, Weinstock MA, et al
    The Global Burden of Melanoma: Results from Global Burden of Disease Study 2015.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15510.
    PubMed     Text format     Abstract available


  5. KOGUCHI-YOSHIOKA H, Okiyama N, Iwamoto K, Matsumura Y, et al
    Intravenous immunoglobulin contributes to control anti-melanoma differentiation-associated protein 5 (MDA5) antibody-associated dermatomyositis with palmar violaceous macules/papules.
    Br J Dermatol. 2017 Mar 27. doi: 10.1111/bjd.15499.
    PubMed     Text format     Abstract available


  6. LICCIARDELLO M, T Giura M, Rozzo G, Marra E, et al
    Arrhythmias in metastatic melanoma patient treated with targeted therapy and ICD implant.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15447.
    PubMed     Text format     Abstract available


  7. RICHTIG G, Hoeller C, Kashofer K, Aigelsreiter A, et al
    Beyond the BRAFV600E hotspot - Biology and clinical implications of rare BRAF gene mutations in melanoma patients.
    Br J Dermatol. 2017 Mar 9. doi: 10.1111/bjd.15436.
    PubMed     Text format     Abstract available


    February 2017
  8. CORR M, Roulston G, King N, Dornan T, et al
    Living with 'melanoma'...for a day: a phenomenological analysis of medical students' simulated experiences.
    Br J Dermatol. 2017 Feb 23. doi: 10.1111/bjd.15402.
    PubMed     Text format     Abstract available


  9. JORDAN M, Ghoreschi K
    Anti-melanoma differentiation-associated protein 5 autoantibodies as a marker for dermatomyositis-associated interstitial lung disease.
    Br J Dermatol. 2017;176:294-295.
    PubMed     Text format    


    January 2017
  10. WOLNER ZJ, Marghoob AA, Pulitzer MP, Postow MA, et al
    A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma.
    Br J Dermatol. 2017 Jan 28. doi: 10.1111/bjd.15354.
    PubMed     Text format     Abstract available


  11. VANHAECKE C, Deilhes F, Chanal J, Regnier-Rosencher E, et al
    BRAFV600 inhibitor discontinuation after complete response in advanced melanoma. A retrospective analysis of 16 patients.
    Br J Dermatol. 2017 Jan 27. doi: 10.1111/bjd.15345.
    PubMed     Text format     Abstract available


  12. KUNTE C, Letule V, Gehl J, Dahlstroem K, et al
    Electrochemotherapy in the treatment of metastatic malignant melanoma: A prospective cohort study by InspECT.
    Br J Dermatol. 2017 Jan 24. doi: 10.1111/bjd.15340.
    PubMed     Text format     Abstract available


  13. MINAGAWA A, Omodaka T, Koga H, Yokokawa Y, et al
    Nail apparatus melanoma thickness is associated with side and age.
    Br J Dermatol. 2017 Jan 24. doi: 10.1111/bjd.15318.
    PubMed     Text format     Abstract available


  14. KINSLER VA, O'Hare P, Bulstrode N, Calonje JE, et al
    Melanoma in congenital melanocytic naevi.
    Br J Dermatol. 2017 Jan 12. doi: 10.1111/bjd.15301.
    PubMed     Text format     Abstract available


    December 2016
  15. NEITTAANMAKI N, Salmivuori M, Polonen I, Jeskanen L, et al
    Hyperspectral imaging in detecting dermal invasion in lentigo maligna melanoma.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15267.
    PubMed     Text format     Abstract available


  16. USHER-SMITH JA, Kassianos AP, Emery JD, Abel GA, et al
    Identifying people at higher risk of melanoma across the U.K.: a primary-care-based electronic survey.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15181.
    PubMed     Text format     Abstract available


  17. RICHTIG G, Richtig E, Kashofer K, Koch L, et al
    Testing and clinical implications for non-V600 BRAF mutations in metastatic NRASmt melanoma.
    Br J Dermatol. 2016 Dec 7. doi: 10.1111/bjd.15222.
    PubMed     Text format     Abstract available


  18. LINOS E, Li WQ, Han J, Li T, et al
    Lifetime UV exposure and Lentigo Maligna Melanoma.
    Br J Dermatol. 2016 Dec 7. doi: 10.1111/bjd.15218.
    PubMed     Text format     Abstract available


  19. SPENDER LC, Inman GJ
    Fatal attractions? Correlations of CXCL12-CXCR4-CXCR7 expression with disease progression in melanoma and Kaposi sarcoma.
    Br J Dermatol. 2016;175:1140-1141.
    PubMed     Text format    


  20. YELAMOS O, Nehal KS
    Integrating clinical information, dermoscopy and reflectance confocal microscopy to improve the diagnostic accuracy and confidence of amelanotic and lightly pigmented melanomas.
    Br J Dermatol. 2016;175:1147-1148.
    PubMed     Text format    


  21. HAASS NK
    JNK-ERK signalling in melanoma: rewired or entangled?
    Br J Dermatol. 2016;175:1139-1140.
    PubMed     Text format    


  22. DIXON A, Steinman H, Anderson S, Nirenberg A, et al
    Routine usage of sentinel node biopsy in melanoma management must cease.
    Br J Dermatol. 2016;175:1340-1341.
    PubMed     Text format    


    November 2016
  23. SPEIGL L, Janssen N, Weide B, Pawelec G, et al
    Prognostic impact of the putative cancer stem cell markers ABCG2, CD133, ALDH1A1 and CD44V7/8 in metastatic melanoma.
    Br J Dermatol. 2016 Nov 21. doi: 10.1111/bjd.15194.
    PubMed     Text format     Abstract available


  24. MAHER NG, Blumetti TP, Gomes EE, Cheng HM, et al
    Melanoma diagnosis may be a pitfall for optical coherence tomography assessment of equivocal amelanotic or hypomelanotic skin lesions.
    Br J Dermatol. 2016 Nov 18. doi: 10.1111/bjd.15187.
    PubMed     Text format     Abstract available


  25. POLESIE S, Gillstedt M, Sonnergren HH, Osmancevic A, et al
    Methotrexate Treatment and Risk for Cutaneous Malignant Melanoma - a Retrospective Comparative Registry-based Cohort Study.
    Br J Dermatol. 2016 Nov 10. doi: 10.1111/bjd.15170.
    PubMed     Text format     Abstract available


  26. BARRETT JH
    Telomere length and melanoma - is there a straightforward relationship?
    Br J Dermatol. 2016;175:865-866.
    PubMed     Text format    


  27. ELLIKER KR, Williams HC
    Detection of skin cancer odours using dogs: a step forward in melanoma detection training and research methodologies.
    Br J Dermatol. 2016;175:851-852.
    PubMed     Text format    


    October 2016
  28. RICHTIG G, Byrom L, Kupsa R, Schaider H, et al
    Pregnancy as driver for melanoma.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15124.
    PubMed     Text format     Abstract available


  29. MAIQUES O, Macia A, Moreno S, Barcelo C, et al
    Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15121.
    PubMed     Text format     Abstract available


  30. O'SHEA SJ, Davies JR, Newton-Bishop JA
    Vitamin D, vitamin A, the primary melanoma transcriptome and survival.
    Br J Dermatol. 2016;175 Suppl 2:30-34.
    PubMed     Text format     Abstract available


    September 2016
  31. PIZZICHETTA MA, Kittler H, Stanganelli I, Ghigliotti G, et al
    Dermoscopic diagnosis of amelanotic/hypomelanotic melanoma.
    Br J Dermatol. 2016 Sep 28. doi: 10.1111/bjd.15093.
    PubMed     Text format     Abstract available


  32. WEINSTOCK MA, Lott JP, Wang Q, Titus LJ, et al
    Skin Biopsy Utilization and Melanoma Incidence among Medicare Beneficiaries.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15077.
    PubMed     Text format     Abstract available


  33. LO MC, Maraka J, Garioch J, John WG, et al
    Monitoring vitamin D in the melanoma patient - impact of sun avoidance on vitamin D levels of melanoma patients at a tertiary UK referral melanoma service.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15062.
    PubMed     Text format     Abstract available


  34. SCHUURMAN MS, de Waal AC, Thijs EJ, van Rossum MM, et al
    Risk factors for second primary melanoma among Dutch melanoma patients.
    Br J Dermatol. 2016 Sep 5. doi: 10.1111/bjd.15024.
    PubMed     Text format     Abstract available


  35. FOX J
    A changing treatment paradigm: the role of palliative care in metastatic melanoma.
    Br J Dermatol. 2016;175:462-3.
    PubMed     Text format    


    August 2016
  36. RIBERO S, Marra E, Tomasini CF, Fierro MT, et al
    Confocal microscopy and dermoscopy for the monitoring of BRAF inhibitor therapy of melanoma skin metastases.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14951.
    PubMed     Text format     Abstract available


  37. RIBERO S, Osella-Abate S, Reyes-Garcia D, Grulich A, et al
    Gender effects on naevi body distribution and melanoma risk in two melanoma case control studies at different latitudes.
    Br J Dermatol. 2016 Aug 1. doi: 10.1111/bjd.14915.
    PubMed     Text format     Abstract available


    July 2016
  38. MANGAS C, Potrony M, Mainetti C, Bianchi E, et al
    Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.
    Br J Dermatol. 2016 Jul 30. doi: 10.1111/bjd.14897.
    PubMed     Text format     Abstract available


  39. WILLIS CM, Britton LE, Swindells MA, Jones EM, et al
    Invasive melanoma in-vivo can be distinguished from basal cell carcinoma, benign naevi and healthy skin by canine olfaction: a proof of principle study of differential volatile organic compound emission.
    Br J Dermatol. 2016 Jul 25. doi: 10.1111/bjd.14887.
    PubMed     Text format     Abstract available


  40. GRANT WB
    Increased risk of non-cutaneous malignancy after diagnosis of non-melanoma skin cancer may be due to sun avoidance.
    Br J Dermatol. 2016 Jul 15. doi: 10.1111/bjd.14862.
    PubMed     Text format     Abstract available


  41. PARDO LM, van der Leest RJ, de Vries E, Soerjomataram I, et al
    Comparing survival of patients with single or multiple primary melanoma in The Netherlands: 1994-2009.
    Br J Dermatol. 2016 Jul 5. doi: 10.1111/bjd.14846.
    PubMed     Text format     Abstract available


  42. KIRBY LC, Banerjee A, Augustine T, Douglas JF, et al
    An ethical dilemma: malignant melanoma in a 51-year-old patient awaiting simultaneous kidney and pancreas transplantation for type 1 diabetes.
    Br J Dermatol. 2016;175:172-4.
    PubMed     Text format     Abstract available


    June 2016
  43. SHITARA D, Tell-Marti G, Badenas C, Enokihara MM, et al
    Discrepant mutational status between naevi and melanomas in naevus-associated melanomas: about mutation-specific immunohistochemistry: reply from the authors.
    Br J Dermatol. 2016 Jun 16. doi: 10.1111/bjd.14613.
    PubMed     Text format    


  44. TEULINGS HE, Lommerts JE, Wolkerstorfer A, Nieuweboer-Krobotova L, et al
    Vitiligo-like depigmentations as first sign of melanoma; a retrospective case series from a tertiary vitiligo centre.
    Br J Dermatol. 2016 Jun 7. doi: 10.1111/bjd.14790.
    PubMed     Text format     Abstract available


  45. STEFANAKI I, Stratigos AJ
    Inherited susceptibility to melanoma: insights from a high-risk Austrian cohort.
    Br J Dermatol. 2016;174:1188-90.
    PubMed     Text format    


    May 2016
  46. RANSOHOFF KJ, Stefanick ML, Li S, Kurian AW, et al
    Association of non-melanoma skin cancer with second non-cutaneous malignancy in the Women's Health Initiative.
    Br J Dermatol. 2016 May 26. doi: 10.1111/bjd.14766.
    PubMed     Text format     Abstract available


  47. TRAUTMANN F, Meier F, Seidler A, Schmitt J, et al
    Effects of the German skin cancer screening program on melanoma incidence and indicators of disease severity.
    Br J Dermatol. 2016 May 20. doi: 10.1111/bjd.14758.
    PubMed     Text format     Abstract available


  48. THURNEYSEN S, Cheng PF, Nagel HW, Kunz M, et al
    An exploratory study investigating the metabolic activity and local cytokine profile in melanoma patients treated with pazopanib and paclitaxel.
    Br J Dermatol. 2016 May 11. doi: 10.1111/bjd.14727.
    PubMed     Text format     Abstract available


  49. MCCONNELL AT, Ellis R, Pathy B, Plummer R, et al
    The prognostic significance and impact of the CXCR4/CXCR7/CXCL12 axis in primary cutaneous melanoma.
    Br J Dermatol. 2016 May 11. doi: 10.1111/bjd.14720.
    PubMed     Text format     Abstract available


  50. PATHRIA G, Garg B, Garg K, Wagner C, et al
    Dual JNK-Cyclin D1 and ERK-c-JUN Disjunction in Human Melanoma.
    Br J Dermatol. 2016 May 5. doi: 10.1111/bjd.14713.
    PubMed     Text format     Abstract available


  51. PIANA S, Moscarella E, Longo C
    Image Gallery: Brain? no, melanoma.
    Br J Dermatol. 2016;174:e41.
    PubMed     Text format    


  52. SCHOFIELD JK, Robinson R, Reeken S, Jackson R, et al
    National Institute for Health and Care Excellence melanoma guidelines: good news for patients but challenging to implement.
    Br J Dermatol. 2016;174:949-50.
    PubMed     Text format    


  53. LLOYD-LAVERY A, Hodgson T, Coupe N, Bond S, et al
    Delayed oral toxicity from long-term vemurafenib therapy.
    Br J Dermatol. 2016;174:1159-60.
    PubMed     Text format    


  54. LALLAS A, Tschandl P, Kyrgidis A, Stolz W, et al
    Dermoscopic clues to differentiate facial lentigo maligna from pigmented actinic keratosis.
    Br J Dermatol. 2016;174:1079-85.
    PubMed     Text format     Abstract available


  55. GREVELING K, de Vries K, van Doorn MB, Prens EP, et al
    A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose.
    Br J Dermatol. 2016;174:1134-6.
    PubMed     Text format    


    April 2016
  56. MENIN C, Bojnik E, Del Bianco P, Elefanti L, et al
    Differences in telomere length between sporadic and familial cutaneous melanoma.
    Br J Dermatol. 2016 Apr 7. doi: 10.1111/bjd.14652.
    PubMed     Text format     Abstract available


  57. GALLAIS SEREZAL I, Beaussant Y, Rochigneux P, Tournigand C, et al
    End-of-life care for hospitalised patients with metastatic melanoma in France: a nationwide, register-based study.
    Br J Dermatol. 2016 Apr 1. doi: 10.1111/bjd.14631.
    PubMed     Text format     Abstract available


  58. HORSHAM C, J Loescher L, Whiteman DC, Soyer HP, et al
    Consumer acceptance of patient-performed mobile teledermoscopy for the early detection of melanoma.
    Br J Dermatol. 2016 Apr 1. doi: 10.1111/bjd.14630.
    PubMed     Text format     Abstract available


  59. OREGAARD JS, Jarjis RD, Venzo A, Jemec B, et al
    Cover Image: Unique presentation of a subungual malignant melanoma in situ.
    Br J Dermatol. 2016;174:935.
    PubMed     Text format    


  60. SULLIVAN RJ
    Serum lactate dehydrogenase is a more useful biomarker of prognosis than serum S100B in patients with BRAF-mutant melanoma.
    Br J Dermatol. 2016;174:716-7.
    PubMed     Text format    


  61. BAADE PD
    Quantifying the mortality burden for skin cancers other than melanoma.
    Br J Dermatol. 2016;174:713-4.
    PubMed     Text format    


  62. NILSEN LT, Hannevik M, Veierod MB
    Ultraviolet exposure from indoor tanning devices: a systematic review.
    Br J Dermatol. 2016;174:730-40.
    PubMed     Text format     Abstract available


    March 2016
  63. UGUEN A
    Discrepant mutational status between naevi and melanomas in naevus-associated melanomas: about mutation-specific immunohistochemistry.
    Br J Dermatol. 2016 Mar 31. doi: 10.1111/bjd.14603.
    PubMed     Text format     Abstract available


  64. PARKINS G, Brown E, Gupta G
    Radiological imaging in all stage III melanoma- current practice in the United Kingdom.
    Br J Dermatol. 2016 Mar 15. doi: 10.1111/bjd.14551.
    PubMed     Text format     Abstract available


  65. PARTARRIEU-MEJIAS F, Perez-Velasquez F
    Image Gallery: Xeroderma pigmentosum.
    Br J Dermatol. 2016;174:e12.
    PubMed     Text format    


  66. DE VRIES K, Greveling K, Prens LM, Munte K, et al
    Recurrence rate of lentigo maligna after micrographically controlled staged surgical excision.
    Br J Dermatol. 2016;174:588-93.
    PubMed     Text format     Abstract available


  67. BELLON T, Lerma V, Gonzalez-Valle O, Gonzalez Herrada C, et al
    Vemurafenib-induced toxic epidermal necrolysis: possible cross-reactivity with other sulfonamide compounds.
    Br J Dermatol. 2016;174:621-4.
    PubMed     Text format     Abstract available


    February 2016
  68. CHAPPUIS P, Duru G, Marchal O, Girier P, et al
    Dermoscopy: A useful tool for general practitioners in melanoma screening: A nationwide survey.
    Br J Dermatol. 2016 Feb 23. doi: 10.1111/bjd.14495.
    PubMed     Text format     Abstract available


  69. STASER K, Chen D, Solus J, Rosman IS, et al
    Extensive tumoral melanosis associated with ipilimumab-treated melanoma.
    Br J Dermatol. 2016 Feb 15. doi: 10.1111/bjd.14474.
    PubMed     Text format     Abstract available


  70. SARGEN MR, Merrill SL, Chu EY, Nathanson KL, et al
    CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic nevi, and internal malignancies: A case series and review of the literature.
    Br J Dermatol. 2016 Feb 15. doi: 10.1111/bjd.14485.
    PubMed     Text format     Abstract available


  71. NALDI L, Cazzaniga S
    Prediction of high total naevus count to estimate melanoma risk. We need more, don't we?
    Br J Dermatol. 2016;174:261-2.
    PubMed     Text format    


  72. LEE S, Duffy DL, McClenahan P, Lee KJ, et al
    Heritability of naevus patterns in an adult twin cohort from the Brisbane Twin Registry: a cross-sectional study.
    Br J Dermatol. 2016;174:356-63.
    PubMed     Text format     Abstract available


    January 2016
  73. MULLER C, Wendt J, Rauscher S, Burgstaller-Muehlbacher S, et al
    Characterization of high risk melanoma patients in Austria.
    Br J Dermatol. 2016 Jan 22. doi: 10.1111/bjd.14407.
    PubMed     Text format     Abstract available


  74. MATTER-WALSTRA K, Braun R, Kolb C, Ademi Z, et al
    Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors.
    Br J Dermatol. 2016 Jan 20. doi: 10.1111/bjd.14279.
    PubMed     Text format    


  75. CHMIELOWSKI B
    Prognostic and predictive biomarkers for the benefit of immunotherapy in patients with metastatic melanoma.
    Br J Dermatol. 2016;174:20.
    PubMed     Text format    


  76. CLIFF SH
    Five-year recurrence rate of lentigo maligna after off-label treatment with imiquimod.
    Br J Dermatol. 2016;174:22-3.
    PubMed     Text format    


  77. KAI AC, Richards T, Coleman A, Mallipeddi R, et al
    Five-year recurrence rate of lentigo maligna after treatment with imiquimod.
    Br J Dermatol. 2016;174:165-8.
    PubMed     Text format     Abstract available


    December 2015
  78. FERNANDEZ-VEGA I, Santos-Juanes J, Fresno-Forcelledo MF
    Primary amelanotic rhabdoid melanoma of the forehead.
    Br J Dermatol. 2015 Dec 29. doi: 10.1111/bjd.14382.
    PubMed     Text format     Abstract available


  79. ROACH RE, Plasmeijer EI, van Doorn R, Bergman W, et al
    The value of clinical characteristics for the diagnosis of melanoma in patients presenting at a pigmented lesion clinic.
    Br J Dermatol. 2015 Dec 26. doi: 10.1111/bjd.14375.
    PubMed     Text format     Abstract available


  80. EISEMANN N, Jansen L, Castro FA, Chen T, et al
    Survival from non-melanoma skin cancer in Germany.
    Br J Dermatol. 2015 Dec 16. doi: 10.1111/bjd.14352.
    PubMed     Text format     Abstract available


  81. FRAUCHIGER AL, Mangana J, Rechsteiner M, Moch H, et al
    Prognostic relevance of LDH and serum S-100 levels in Stage IV melanoma with known BRAF mutation status.
    Br J Dermatol. 2015 Dec 13. doi: 10.1111/bjd.14347.
    PubMed     Text format     Abstract available


  82. CURL PK
    Navigating uncertainty: a valuable cost-effectiveness analysis in the rapidly changing field of metastatic melanoma treatment.
    Br J Dermatol. 2015;173:1365-6.
    PubMed     Text format    


  83. MILLINGTON GW
    Growth and hormonal profiling in children with congenital melanocytic naevi.
    Br J Dermatol. 2015;173:1366-7.
    PubMed     Text format    


    November 2015
  84. TSCHANDL P, Berghoff AS, Preusser M, Pammer J, et al
    Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and nevi in vivo.
    Br J Dermatol. 2015 Nov 28. doi: 10.1111/bjd.14323.
    PubMed     Text format     Abstract available


  85. MONCRIEFF M, Fadhil M, Garrioch J
    Topical diphencyprone for the treatment of locoregional intralymphatic melanoma metastases (LIMMs) of the skin. The 5-Year Norwich experience.
    Br J Dermatol. 2015 Nov 24. doi: 10.1111/bjd.14314.
    PubMed     Text format     Abstract available


  86. GUIDA S, Pellacani G, Cesinaro AM, Moscarella E, et al
    Spitz naevi and melanomas with similar dermoscopic pattern: can confocal microscopy differentiate?
    Br J Dermatol. 2015 Nov 11. doi: 10.1111/bjd.14286.
    PubMed     Text format     Abstract available


  87. SEBARATNAM DF, Anforth R, Fernandez-Penas P
    Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma.
    Br J Dermatol. 2015 Nov 2. doi: 10.1111/bjd.14264.
    PubMed     Text format     Abstract available


    October 2015
  88. RIBERO S, Zugna D, Osella-Abate S, Glass D, et al
    Prediction of high naevus count in a healthy UK population to estimate melanoma risk.
    Br J Dermatol. 2015 Oct 19. doi: 10.1111/bjd.14216.
    PubMed     Text format     Abstract available


    September 2015
  89. MOSER J, Moshammer R, Koglbauer G, Kitzwogerer M, et al
    Sentinel-node biopsy in melanoma: A single center experience with 216 consecutive patients.
    Br J Dermatol. 2015 Sep 24. doi: 10.1111/bjd.14189.
    PubMed     Text format     Abstract available


  90. ZARAGOZA J, Caille A, Beneton N, Bens G, et al
    Neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma.
    Br J Dermatol. 2015 Sep 6. doi: 10.1111/bjd.14155.
    PubMed     Text format     Abstract available


  91. MATTER-WALSTRA K, Braun R, Kolb C, Ademi Z, et al
    A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-positive melanoma in the Swiss setting.
    Br J Dermatol. 2015 Sep 2. doi: 10.1111/bjd.14152.
    PubMed     Text format     Abstract available


  92. KRAFT S, Tsao H
    Melanoma-associated naevi: precursors or coincidence?
    Br J Dermatol. 2015;173:633-4.
    PubMed     Text format    


  93. SCHOFIELD JK
    Sentinel lymph node biopsy: in support of equity of access, informed shared decision making and patient choice.
    Br J Dermatol. 2015;173:863-4.
    PubMed     Text format    


    August 2015
  94. CHAVEZ-BOURGEOIS M, Iglesias P, Brito J, Malvehy J, et al
    Skin cancers detected as casual findings with Reflectance Confocal Microscopy (RCM) in the assessment of melasma treatment.
    Br J Dermatol. 2015 Aug 12. doi: 10.1111/bjd.14066.
    PubMed     Text format     Abstract available


  95. MONCRIEFF M, Garioch J
    MSLT-I: it's all about the lymph nodes....
    Br J Dermatol. 2015;173:626-7.
    PubMed     Text format    


  96. MCGREGOR JM, Sasieni P
    MSLT-I: it's all about the lymph nodes...: reply from the authors.
    Br J Dermatol. 2015;173:627-8.
    PubMed     Text format    


    July 2015
  97. BENATI E, Argenziano G, Kyrgidis A, Moscarella E, et al
    Melanoma and naevi with globular pattern: Confocal microscopy as an aid for diagnostic differentiation.
    Br J Dermatol. 2015 Jul 25. doi: 10.1111/bjd.14049.
    PubMed     Text format     Abstract available


  98. LALLAS A, Kyrgidis A, Koga H, Moscarella E, et al
    The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma.
    Br J Dermatol. 2015 Jul 25. doi: 10.1111/bjd.14045.
    PubMed     Text format     Abstract available


  99. LI Z, Wang Z, Yu Y, Zhang H, et al
    Smoking is Inversely Related to Cutaneous Malignant Melanoma -Says Results from a Meta-analysis.
    Br J Dermatol. 2015 Jul 2. doi: 10.1111/bjd.13998.
    PubMed     Text format     Abstract available


  100. DAVIES MA
    BRAF in early stage melanoma: rationale for testing and treatment?
    Br J Dermatol. 2015;173:9-10.
    PubMed     Text format    


  101. GOHARA M
    Skin cancer: an African perspective.
    Br J Dermatol. 2015;173 Suppl 2:17-21.
    PubMed     Text format     Abstract available


    June 2015
  102. SINHA R, Larkin J, Gore M, Fearfield L, et al
    Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF mutation-positive metastatic melanoma, including recognition and management of rare presentations.
    Br J Dermatol. 2015 Jun 24. doi: 10.1111/bjd.13958.
    PubMed     Text format     Abstract available


  103. BENATI E, Zalaudek I, Piana S, Argenziano G, et al
    In vivo detection of peripheral clefting in melanocytic lesions.
    Br J Dermatol. 2015 Jun 23. doi: 10.1111/bjd.13959.
    PubMed     Text format     Abstract available


  104. FINNANE A, Soyer HP
    Smartphone diagnosis of skin cancer: there's not yet an app for that.
    Br J Dermatol. 2015;172:1474-5.
    PubMed     Text format    


  105. WU S
    Do mutations in BRCA1/BRCA2 confer a higher risk of skin cancer?
    Br J Dermatol. 2015;172:1473.
    PubMed     Text format    


  106. GUMASTE PV, Penn LA, Cymerman RM, Kirchhoff T, et al
    Skin cancer risk in BRCA1/2 mutation carriers.
    Br J Dermatol. 2015;172:1498-506.
    PubMed     Text format     Abstract available


  107. VIGARIOS E, Lamant L, Delord JP, Fricain JC, et al
    Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors.
    Br J Dermatol. 2015;172:1680-2.
    PubMed     Text format    


    May 2015
  108. THOMAS L
    Dermoscopy for melanoma: don't forget to take a photo.
    Br J Dermatol. 2015;172:1182-3.
    PubMed     Text format    


    April 2015
  109. JAFARI SM, Hunger RE, Shafighi M
    Lack of strong evidence in depth of thick melanoma excision.
    Br J Dermatol. 2015 Apr 27. doi: 10.1111/bjd.13871.
    PubMed     Text format     Abstract available


  110. PIZZICHETTA MA, Kittler H, Stanganelli I, Bono R, et al
    Pigmented nodular melanoma: The predictive value of dermoscopic features using a multivariate analysis.
    Br J Dermatol. 2015 Apr 27. doi: 10.1111/bjd.13861.
    PubMed     Text format     Abstract available


  111. SHITARAA D, Tell-Marti G, Badenas C, Enokihara MM, et al
    Mutational status of nevus associated-melanomas.
    Br J Dermatol. 2015 Apr 9. doi: 10.1111/bjd.13829.
    PubMed     Text format     Abstract available


  112. MARCHIORI BAKOS R
    Dermoscopy of naevoid melanoma.
    Br J Dermatol. 2015;172:848-9.
    PubMed     Text format    


  113. IDORN LW
    New insights into the association of socioeconomic status with cutaneous malignant melanoma.
    Br J Dermatol. 2015;172:846-7.
    PubMed     Text format    


  114. OAKLEY AM
    Mobile teledermatology is here to stay.
    Br J Dermatol. 2015;172:856-7.
    PubMed     Text format    


  115. MANAHAN MN, Soyer HP, Loescher LJ, Horsham C, et al
    A pilot trial of mobile, patient-performed teledermoscopy.
    Br J Dermatol. 2015;172:1072-80.
    PubMed     Text format     Abstract available


  116. DEBARBIEUX S, Gaspar R, Depaepe L, Dalle S, et al
    Intraoperative diagnosis of nonpigmented nail tumours with ex vivo fluorescence confocal microscopy: 10 cases.
    Br J Dermatol. 2015;172:1037-44.
    PubMed     Text format     Abstract available


    March 2015
  117. MAR VJ, Liu W, Devitt B, Wong SQ, et al
    The role of BRAF mutations in primary melanoma growth rate and survival.
    Br J Dermatol. 2015 Mar 5. doi: 10.1111/bjd.13756.
    PubMed     Text format     Abstract available


  118. FARIES MB, Cochran AJ, Elashoff RM, Thompson JF, et al
    Multicenter Selective Lymphadenectomy Trial-I confirms the central role of sentinel node biopsy in contemporary melanoma management: Response to 'No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal
    Br J Dermatol. 2015;172:571-3.
    PubMed     Text format     Abstract available


  119. SLADDEN M, Zagarella S, Popescu C, Bigby M, et al
    No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.
    Br J Dermatol. 2015;172:566-71.
    PubMed     Text format     Abstract available


  120. ATTARD NR
    Head and neck melanoma: pattern of sun exposure and histological subtypes.
    Br J Dermatol. 2015;172:560-1.
    PubMed     Text format    


  121. SWETTER SM
    Thinner melanomas and improved survival among men in Sweden from 1997 to 2011.
    Br J Dermatol. 2015;172:559-60.
    PubMed     Text format    


  122. MCGREGOR JM, Sasieni P
    Sentinel node biopsy in cutaneous melanoma: time for consensus to better inform patient choice.
    Br J Dermatol. 2015;172:552-4.
    PubMed     Text format    


    February 2015
  123. CARRERA C
    High-risk melanoma patients: can unnecessary naevi biopsies be avoided?
    Br J Dermatol. 2015;172:313-5.
    PubMed     Text format    


    January 2015
  124. LONGO C, Moscarella E, Argenziano G, Lallas A, et al
    Reflectance confocal microscopy in the diagnosis of solitary pink skin tumors: Review of Diagnostic Clues.
    Br J Dermatol. 2015 Jan 30. doi: 10.1111/bjd.13689.
    PubMed     Text format     Abstract available


  125. KASSIANOS AP, Emery JD, Murchie P, Walter FM, et al
    Smartphone applications for melanoma detection by community, patient and generalist clinician users: a review.
    Br J Dermatol. 2015 Jan 20. doi: 10.1111/bjd.13665.
    PubMed     Text format     Abstract available


  126. JEUDY G, Dalac-Rat S, Bonniaud B, Hervieu A, et al
    Successful switch to dabrafenib after vemurafenib-induced toxic epidermal necrolysis.
    Br J Dermatol. 2015;172:1454-5.
    PubMed     Text format    


  127. RICHTIG E, Arzberger E, Hofmann-Wellenhof R, Fink-Puches R, et al
    Assessment of changes in lentigo maligna during radiotherapy by in-vivo reflectance confocal microscopy: a pilot study.
    Br J Dermatol. 2015;172:81-7.
    PubMed     Text format     Abstract available


    December 2014
  128. LIVINGSTONE E, Eigentler TK, Windemuth-Kieselbach C, Hauschild A, et al
    Actual practice of melanoma follow-up and treatment in Germany: Results of a prospective, longitudinal cohort study.
    Br J Dermatol. 2014 Dec 15. doi: 10.1111/bjd.13612.
    PubMed     Text format     Abstract available


  129. MORTON RL
    Essential inputs for studies of cost-effectiveness analysis in melanoma.
    Br J Dermatol. 2014;171:1294-5.
    PubMed     Text format    


  130. NALDI L
    Melanoma excision: how deep must we go?
    Br J Dermatol. 2014;171:1291-2.
    PubMed     Text format    


  131. BERMUDEZ Y
    Ultraviolet involvement in melanocyte transformation to melanoma.
    Br J Dermatol. 2014;171:1289.
    PubMed     Text format    


    November 2014
  132. GONZALEZ-ALVAREZ T, Carrera C, Bennassar A, Vilalta A, et al
    Dermoscopy structures predictors of sentinel lymph node positivity in cutaneous melanoma.
    Br J Dermatol. 2014 Nov 21. doi: 10.1111/bjd.13552.
    PubMed     Text format     Abstract available


  133. HUNGER RE, Seyed Jafari SM, Angermeier S, Shafighi M, et al
    Excision of fascia in melanoma thicker than 2 mm: no evidence for improved clinical outcome.
    Br J Dermatol. 2014 Nov 13. doi: 10.1111/bjd.13478.
    PubMed     Text format     Abstract available


  134. LONGO C, Piana S, Marghoob A, Cavicchini S, et al
    Morphologic features of nevoid melanoma Results of a Multicenter Study of the International Dermoscopy Society.
    Br J Dermatol. 2014 Nov 12. doi: 10.1111/bjd.13524.
    PubMed     Text format     Abstract available


  135. GARCIA-CASADO Z, Traves V, Banuls J, Niveiro M, et al
    BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
    Br J Dermatol. 2014 Nov 10. doi: 10.1111/bjd.13521.
    PubMed     Text format     Abstract available


  136. KITTLER H
    B-RAF, naevi and melanoma: a complex relationship.
    Br J Dermatol. 2014;171:931-932.
    PubMed     Text format    


    August 2014
  137. MOSCARELLA E, Al Jalbout S, Piana S, Argenziano G, et al
    The stars within the melanocytic garden: Unusual variants of Spitz nevi.
    Br J Dermatol. 2014 Aug 13. doi: 10.1111/bjd.13347.
    PubMed     Text format     Abstract available


  138. LAWRENCE CM, Rahim R, Charlton F, Husain A, et al
    Prospective study of formalin-fixed Mohs surgery and haematoxylin and eosin stains with control contralateral biopsies for lentigo maligna: 5-year follow-up results.
    Br J Dermatol. 2014;171:298-303.
    PubMed     Text format     Abstract available


    July 2014
  139. BRUGIERE C, Stefan A, Morice C, Cornet E, et al
    Vemurafenib skin phototoxicity is indirectly linked to UVA-MED decrease.
    Br J Dermatol. 2014 Jul 26. doi: 10.1111/bjd.13300.
    PubMed     Text format     Abstract available


    May 2014
  140. PELLACANI G, Pepe P, Casari A, Longo C, et al
    Reflectance confocal microscopy as a second-level examination in skin oncology improves diagnostic accuracy and saves unnecessary excisions: a longitudinal prospective study.
    Br J Dermatol. 2014 May 29. doi: 10.1111/bjd.13148.
    PubMed     Text format     Abstract available


    April 2014
  141. KOSE K, Cordova M, Duffy M, Flores ES, et al
    Video-Mosaicing of Reflectance Confocal Images For Examination of Extended Areas of Skin In Vivo.
    Br J Dermatol. 2014 Apr 10. doi: 10.1111/bjd.13050.
    PubMed     Text format     Abstract available


    February 2014
  142. SACHSE MM, Wagner G
    Clearance of BRAF inhibitor-associated keratoacanthomas by systemic retinoids.
    Br J Dermatol. 2014;170:475-7.
    PubMed     Text format    


    January 2014
  143. ECHEVERRIA B, Bulliard JL, Guillen C, Nagore E, et al
    Indicators for the total number of melanocytic naevi: an adjunct for screening campaigns. Observational study on 292 patients.
    Br J Dermatol. 2014;170:144-9.
    PubMed     Text format     Abstract available


  144. RIVERS JK
    Skin cancer: more than skin deep?
    Br J Dermatol. 2014;170:8.
    PubMed     Text format    


  145. FOGARTY GB, Hong A, Scolyer RA, Lin E, et al
    Radiotherapy for lentigo maligna: a literature review and recommendations for treatment.
    Br J Dermatol. 2014;170:52-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: